CYP4Z1
Basic information
Region (hg38): 1:47067231-47118318
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP4Z1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 3 | 1 |
Variants in CYP4Z1
This is a list of pathogenic ClinVar variants found in the CYP4Z1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-47067501-C-G | not specified | Uncertain significance (Feb 15, 2023) | ||
1-47067528-C-G | not specified | Uncertain significance (Mar 29, 2022) | ||
1-47067554-A-C | not specified | Likely benign (Jan 26, 2022) | ||
1-47067602-T-C | not specified | Likely benign (Jun 29, 2022) | ||
1-47068656-A-G | not specified | Uncertain significance (Mar 15, 2024) | ||
1-47068695-T-A | not specified | Uncertain significance (Sep 25, 2024) | ||
1-47068740-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
1-47082343-T-C | not specified | Uncertain significance (Jul 09, 2024) | ||
1-47082433-T-C | not specified | Uncertain significance (Nov 09, 2023) | ||
1-47082451-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
1-47084635-C-A | not specified | Uncertain significance (Oct 13, 2023) | ||
1-47084636-A-C | not specified | Uncertain significance (Apr 01, 2024) | ||
1-47084653-C-T | not specified | Likely benign (Jun 30, 2023) | ||
1-47084659-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
1-47084685-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
1-47084702-T-C | not specified | Uncertain significance (Apr 12, 2024) | ||
1-47084705-A-G | not specified | Uncertain significance (Dec 03, 2021) | ||
1-47084743-A-T | not specified | Uncertain significance (Mar 02, 2023) | ||
1-47084862-G-A | not specified | Uncertain significance (Jul 17, 2024) | ||
1-47084879-C-A | not specified | Uncertain significance (Sep 21, 2023) | ||
1-47084879-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
1-47084897-C-T | not specified | Uncertain significance (Feb 02, 2022) | ||
1-47084952-T-C | not specified | Uncertain significance (Nov 08, 2021) | ||
1-47084963-C-T | not specified | Uncertain significance (Dec 02, 2024) | ||
1-47094583-C-T | not specified | Uncertain significance (Dec 21, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP4Z1 | protein_coding | protein_coding | ENST00000334194 | 12 | 50832 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.87e-17 | 0.00360 | 124323 | 32 | 1393 | 125748 | 0.00568 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.111 | 260 | 265 | 0.981 | 0.0000137 | 3370 |
Missense in Polyphen | 85 | 90.105 | 0.94334 | 1022 | ||
Synonymous | 1.11 | 80 | 93.6 | 0.855 | 0.00000463 | 913 |
Loss of Function | -0.219 | 25 | 23.8 | 1.05 | 0.00000114 | 290 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000775 | 0.000774 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.00688 | 0.00687 |
Finnish | 0.000186 | 0.000185 |
European (Non-Finnish) | 0.000429 | 0.000387 |
Middle Eastern | 0.00688 | 0.00687 |
South Asian | 0.0429 | 0.0402 |
Other | 0.00379 | 0.00359 |
dbNSFP
Source:
- Pathway
- Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Tyrosine metabolism;Androgen and estrogen biosynthesis and metabolism;Leukotriene metabolism;Linoleate metabolism;C21-steroid hormone biosynthesis and metabolism;Xenobiotics metabolism;Arachidonic acid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.797
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.354
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0160
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- oxidation-reduction process
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane;organelle membrane
- Molecular function
- iron ion binding;heme binding;aromatase activity